UCLA-BU Stanford Molecular and Cellular Characterization Laboratory (Lung)

Dr. Dubinett and team seek to understand the pathways underlying heterogeneity in screen-detected lung cancers through both integrated systems analysis of molecular, microenvironment and imaging characteristics of screen-detected lesions, and comparison of molecular and cellular characteristics between screen-detected and non-screen-detected tumors.